His Excellency the CEO of the Saudi Food and Drug Authority (SFDA), Dr. Hisham bin Saad Aljadhey, met during his recent official visit to the United Kingdom, a number of CEOs of British companies, businessmen and representatives of the private sector.

The Saudi Food and Drug Authority (SFDA) organized a virtual training workshop for employees of the Bahraini National Health Regulatory Authority, entitled "Principles of Good Manufacturing Practice (GMP) and Inspection Procedures", as part of the continuous cooperation between SFDA and the Bahraini National Health Regulatory Authority

The Saudi Food and Drug Authority (SFDA) signed on April 12, 2022 a memorandum of cooperation (MoC) with the Saudi Epilepsy Society (SES). The MoC aims to promote and develope the professional, research work of professional specialists and educating the community about epilepsy diseases.

The MOC was signed by His Excellency SFDA’s CEO, Dr. Hisham bin Saad Aljadhey, and SES Chairman Dr. Faisal bin Aboud Al-Otaibi.

The Saudi Food and Drug Authority (SFDA) has detected 19 facilities that violated the Law of Pharmaceutical Establishments and Preparations during January of 2022, due to their lack of commitment to provide pharmaceutical products to the local market.